Children's Qnasl 40 mcg — Class III drug recall D-1453-2016
Terminated recall by Teva North America, reported 2016-08-10, distributed nationwide. Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.
| Recall number | D-1453-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva North America, Horsham, PA, United States |
| Recall initiated | 2016-07-15 |
| Classified | 2016-08-02 |
| Reported by FDA | 2016-08-10 |
| Terminated | 2017-03-10 |
| Distributed | Nationwide (US) |
| Quantity | 193,320 canisters |
| Reason classes | specification failure |
| NDC | 59310-0206-08 |
| Lot numbers | 10/17, 150328 |
Product
Children's Qnasl 40 mcg (beclomethasone dipropionate) Nasal Aerosol, 40 mcg per spray, 60 Metered Sprays per canister, 4.9g Net Contents, Rx only; Professional Sample; Manufactured for Teva Respiratory, LLC, Horsham, PA 19044; By: 3M Drug Delivery Systems, Northridge, CA 91324; NDC 59310-206-08.
Reason for recall
Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1453-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.